Q32 Bio (QTTB) Assets Average (2018 - 2026)
Q32 Bio (QTTB) posted quarterly Assets Average of $62.7 million for Q1 2026, down 26.81% year-over-year from $85.7 million in Q1 2025, and up 4.93% quarter-over-quarter from $59.8 million in Q4 2025.
Q32 Bio (QTTB) Assets Average (2018 - 2026) Analysis & Trends
Q32 Bio's Assets Average history runs 9 years deep, the most recent figure standing at $62.7 million for Q1 2026.
- In Q1 2026, Assets Average fell 26.81% year-over-year to $62.7 million; the TTM figure through Mar 2026 stood at $62.7 million (down 26.81% YoY), while the FY2025 annual figure was $77.1 million, up 10.56% from the prior year.
- Assets Average for Q1 2026 stood at $62.7 million, up from $59.8 million in the prior quarter.
- The five-year high for Assets Average was $297.8 million in Q2 2022, with the low at $59.8 million in Q4 2025.
- The 5-year median for Assets Average is $114.4 million (2024), against an average of $148.1 million.
- The sharpest annual moves came in 2022 and 2023: Assets Average increased 20.65% in 2022, then slumped 61.9% in 2023.
- Q32 Bio's Assets Average stood at $245.6 million in 2022, then plunged by 61.9% to $93.6 million in 2023, then increased by 5.21% to $98.4 million in 2024, then plunged by 39.27% to $59.8 million in 2025, then increased by 4.93% to $62.7 million in 2026.
- Business Quant data shows QTTB's Assets Average at $62.7 million in Q1 2026, $59.8 million in Q4 2025, and $62.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Q32 Bio | 359.61 Mn | 253.31 Mn | - | 89.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89.77 Mn |
| Mar 31, 2026 | 62.73 Mn |
| Dec 31, 2025 | 59.78 Mn |
| Sep 30, 2025 | 61.95 Mn |
| Jun 30, 2025 | 72.59 Mn |
| Mar 31, 2025 | 85.70 Mn |
| Dec 31, 2024 | 98.44 Mn |
| Sep 30, 2024 | 114.37 Mn |
| Jun 30, 2024 | 138.27 Mn |
| Mar 31, 2024 | 99.70 Mn |
| Dec 31, 2023 | 93.56 Mn |
| Sep 30, 2023 | 154.70 Mn |
| Jun 30, 2023 | 183.61 Mn |
| Mar 31, 2023 | 213.18 Mn |
| Dec 31, 2022 | 245.56 Mn |
| Sep 30, 2022 | 273.63 Mn |
| Jun 30, 2022 | 297.78 Mn |
| Mar 31, 2022 | 261.34 Mn |
| Dec 31, 2021 | 221.27 Mn |
| Sep 30, 2021 | 244.87 Mn |